Temozolomide in Treating Patients With Anaplastic Oligodendroglioma

Clinical trial NCT00003465 · COMPLETED

Trial details

NCT number: NCT00003465
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors

Start date: 1998-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.